802. Chemical Biology and Experimental Therapeutics: Poster III

Selective degradation of oncogenic signaling nodes by momelotinib based protacs exerts potent anti leukemic response in B ALL AML and MF while sparing normal cells

GB3226 a novel orally active first in class small molecule inhibitor of ENL yeats and FLT3 kinase for the treatment of Relapsed Refractory Acute Myeloid Leukemia

Synergistic antitumor effects and mechanisms of KPT 330 combined with venetoclax in Acute Myeloid Leukemia

Inhibition of the aryl hydrocarbon receptor eliminates leukemia stem cells in murine models of Acute Myeloid Leukemia

High throughput screening uncloaks actionable compounds for ttmv rara AML